Futibatinib is an FGFR inhibitor. It’s specifically made to treat cholangiocarcinoma, which is caused by FGFR2 fusions. How it works? It blocks FGFR signaling pathways.
You take it as 4 mg tablets. The usual dose is 20 mg, taken just once every day. These tablets come in bottles, each with 28 tablets.
It’s a generic drug. You should take it with a doctor’s guidance. It’s pretty special because it goes after cholangiocarcinoma cells with FGFR2 fusions.
That makes it different from other cancer treatments.
